Scout | FOR-FD-25-001: Clinical Trials for New Indications in Rare Neurodegenerative Diseases (R01)

forecast FOR-FD-25-001

Clinical Trials for New Indications in Rare Neurodegenerative Diseases (R01)

Summary

This R01 funds clinical trials testing the safety and/or efficacy of products to support new indications or labeling changes that address unmet needs in rare neurodegenerative diseases for children and adults. It prioritizes collaborative, efficient, and innovative trial designs to accelerate FDA approval of treatments and advance rare disease drug development. Funded studies should directly s…

The purpose is to fund clinical trials of products evaluating efficacy and/or safety in support of a new indication or change in labeling to address unmet needs in rare neurodegenerative diseases for children and adults. Through the support of collaborative, efficient, and/or innovative clinical…

Funding Source

Agency: Food and Drug Administration

Awards & funding

Award Ceiling: $900,000

Award Floor: $650,000

Eligibility

Native American tribal organizations (other than Federally recognized tribal governments)

Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education

Public and State controlled institutions of higher education

Small businesses

State governments

Supporting links

grants.gov

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers